Clinical Trial Update: Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying the acute metabolic effects of tirzepatide in individuals with Type 1 diabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mounjaro (tirzepatide) (tirzepatide)

Snippet

Sponsor: Garvan Institute of Medical Research | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: NOT_YET_RECRUITING